Horimoto, Y., Arakawa, A., Sasahara, N., Tanabe, M., Sai, S., Himuro, T., & Saito, M. (2016). Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases. PLoS One.
Citação norma ChicagoHorimoto, Yoshiya, Atsushi Arakawa, Noriko Sasahara, Masahiko Tanabe, Sei Sai, Takanori Himuro, and Mitsue Saito. "Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 As a Prognostic Indicator in Breast Cancer Patients With Distant Metastases." PLoS One 2016.
Citação norma MLAHorimoto, Yoshiya, et al. "Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 As a Prognostic Indicator in Breast Cancer Patients With Distant Metastases." PLoS One 2016.